Martina Morelli - Concepedia

Author

Martina Morelli

Istituti di Ricovero e Cura a Carattere Scientifico ORCID

Also Known As

M Morelli, M. Morelli, Martina Morelli

Publications

725

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico University of Verona Istituto Dermopatico dell'Immacolata Istituto Superiore di Sanità Centro Interuniversitario di Ricerca sui Peptidi Bioattivi

About

Martina Morelli is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, inflammation, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	277
2	Immunology	4	4	277
3	Allergy	1	1	33
4	Cell Biology	1	1	16
5	Autism	1	1	165

Martina Morelli

Publications

666

Citations

H-Index

Page 1

	Year	Citations
Altered Cytokine and BDNF Levels in Autism Spectrum Disorder Serafino Ricci, Rita Businaro, Flora Ippoliti, Neurotoxicity Research InflammationSyndromic AutismMedicineImmunologyAutism	2013	165
IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment Laura Mercurio, Martina Morelli, Claudia Scarponi, Cell Death and Disease	2018	126
Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses Laura Mercurio, Cristina Maria Failla, Lorena Capriotti, PLoS ONE Endothelial CellsImmunologyImmune RegulationCell ProliferationInnate Immunity	2020	63
Enhanced NAMPT-Mediated NAD Salvage Pathway Contributes to Psoriasis Pathogenesis by Amplifying Epithelial Auto-Inflammatory Circuits Laura Mercurio, Martina Morelli, Claudia Scarponi, International Journal of Molecular Sciences	2021	50
IL‐17C amplifies epithelial inflammation in human psoriasis and atopic eczema Felix Lauffer, Manja Jargosch, V. Baghin, Journal of the European Academy of Dermatology and Venereology	2019	47
Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis Martina Morelli, Claudia Scarponi, Laura Mercurio, Journal of Immunology Research	2018	45
<i>HLA-Cw6</i> and other HLA-C alleles, as well as <i>MICB-DT, DDX58,</i> and <i>TYK2</i> genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis Martina Morelli, Marco Galluzzo, Stefania Madonna, Expert Opinion on Biological Therapy	2020	36
Paradoxical psoriasis induced by TNF‐α blockade shows immunological features typical of the early phase of psoriasis development Luca Fania, Martina Morelli, Claudia Scarponi, The Journal of Pathology Clinical Research Psoriasis DevelopmentImmune RegulationImmunologyInnate ImmunityDermatology	2019	33
Intracellular Insulin-like growth factor binding protein 2 (IGFBP2) contributes to the senescence of keratinocytes in psoriasis by stabilizing cytoplasmic p21 Laura Mercurio, Daniela Lulli, Francesca Mascia, Aging	2020	32
SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes Stefania Madonna, Claudia Scarponi, Martina Morelli, Oncotarget	2017	28

Page 1